[1]施 洋,向蔚婷,毛玉琴,等.2型糖尿病患者微血管并发症危险因素相关性分析[J].医学信息,2025,38(02):92-96148.[doi:10.3969/j.issn.1006-1959.2025.02.016]
　SHI Yang,XIANG Weiting,MAO Yuqin,et al.Correlation Analysis of Risk Factors of Microvascular Complications in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2025,38(02):92-96148.[doi:10.3969/j.issn.1006-1959.2025.02.016]
点击复制

2型糖尿病患者微血管并发症危险因素相关性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年02期
页码:
92-96148
栏目:
论著
出版日期:
2025-01-15

文章信息/Info

Title:
Correlation Analysis of Risk Factors of Microvascular Complications in Patients with Type 2 Diabetes Mellitus
文章编号:
1006-1959（2025）02-0092-06
作者:
施 洋1; 向蔚婷2; 毛玉琴2; 雒肖艳2; 吴胜利2; 朱玉婧2
克拉玛依市中西医结合医院<市人民医院>药剂科1，内分泌代谢中心2，新疆 克拉玛依 834000
Author(s):
SHI Yang1;  XIANG Weiting2;  MAO Yuqin2;  LUO Xiaoyan2;  WU Shengli2;  ZHU Yujing2
Department of Pharmacy1, Endocrine Metabolism Center2, Karamay Municipal Hospital of Integrated Traditional Chinese and Western Medicine , Karamay 834000, Xinjiang，China
关键词:
2型糖尿病; 微血管并发症; Logit回归; 危险因素; 糖尿病视网膜病变; 糖尿病周围神经病变; 临床蛋白尿
Keywords:
Type 2 diabetes mellitus;  Microvascular complications;  Logit regression;  Risk factors;  Diabetic retinopathy;  Diabetic peripheral neuropathy;  Clinical proteinuria
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2025.02.016
文献标志码:
A
摘要:
目的 应用Logit回归分析2型糖尿病患者（T2DM）微血管并发症的危险因素，探究其相关性。方法 筛选2018年1月-2020年12月于克拉玛依市中西医结合医院住院的T2DM患者1574例，对性别、年龄、吸烟、高血脂病史等进行Logit模型多元回归分析，评价影响T2DM微血管并发症相关3种疾病：糖尿病视网膜病变、糖尿病周围神经病变、临床蛋白尿的危险因素。结果 Logit回归分析结果显示，糖尿病视网膜病变与年龄、糖尿病病程、糖尿病治疗情况、脂肪肝等因素相关（P＜0.05）；糖尿病周围神经病变与年龄、吸烟史、高脂血病史、日吸烟量、空腹血糖、餐后2 h血糖、糖化血红蛋白（HbA1c）、每月酒精量、糖尿病治疗情况、高血压治疗情况等因素相关（P＜0.05）；临床蛋白尿与高脂血病史、糖尿病病程、低密度脂蛋白（LDL）、收缩压、糖尿病治疗情况、脂肪肝、高血压治疗情况等因素相关（P＜0.05）。结论 T2DM微血管并发症与多种危险因素呈现相关性，重视微血管病变，减少相关危险因素，加强T2DM患者并发症的防治和管理，可有效改善患者预后，提高其生活质量。
Abstract:
Objective To analyze the risk factors of microvascular complications in patients with type 2 diabetes mellitus (T2DM) by Logit regression, and to explore its correlation. Methods A total of 1574 patients with T2DM who were hospitalized in Karamay Municipal Hospital of Integrated Chinese and Western Medicine from January 2018 to December 2020 were screened. Logit model multiple regression analysis was performed on gender, age, smoking, and history of hyperlipidemia to evaluate the risk factors of three diseases related to microvascular complications of T2DM: diabetic retinopathy, diabetic peripheral neuropathy, and clinical proteinuria. Results The results of Logit regression analysis showed that diabetic retinopathy was related to age, duration of diabetes, treatment of diabetes, fatty liver and other factors (P<0.05). Diabetic peripheral neuropathy was associated with age, smoking history, history of hyperlipidemia, daily smoking, fasting blood glucose, 2 h postprandial blood glucose, glycosylated hemoglobin (HbA1c), monthly alcohol consumption, diabetes treatment, hypertension treatment and other factors (P<0.05). Clinical proteinuria was associated with history of hyperlipidemia, duration of diabetes, low density lipoprotein (LDL), systolic blood pressure, treatment of diabetes, fatty liver, treatment of hypertension and other factors (P<0.05). Conclusion Microvascular complications of T2DM are correlated with a variety of risk factors. Paying attention to microvascular lesions, reducing related risk factors, and strengthening the prevention and management of complications in T2DM patients can effectively improve the prognosis of patients and improve their quality of life.

参考文献/References:

[1]Faselis C,Katsimardou A,Imprialos K,et al.Microvascular Complications of Type 2 Diabetes Mellitus[J].Curr Vasc Pharmacol,2020,18(2):117-124.[2]Ogurtsova K,da Rocha Fernandes JD,Huang Y,et al.IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040[J].Diabetes Res Clin Pract,2017,128:40-50.[3]陈灏珠,钟南山,陆再英.内科学[M].9版.北京:人民卫生出版社,2018:725-728.[4]Forbes JM,Cooper ME.Mechanisms of diabetic complications[J].Physiol Rev,2013,93(1):137-188.[5]American Diabetes Association.11.Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2021[J].Diabetes Care,2021,44(Suppl 1):S151-S167.[6]郭延云,杜益君,钟兴,等.2型糖尿病并发痛性糖尿病神经病变的危险因素分析[J].中国糖尿病杂志,2022,30(10):737-740.[7]钟学礼(执笔).全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-683.[8]Li Y,Teng D,Shi X,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J].BMJ,2020,369:m997.[9]Solini A,Penno G,Bonora E,et al.Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study[J].Diabetes Care,2012,35(1):143-149.[10]Voigt M,Schmidt S,Lehmann T,et al.Prevalence and Progression Rate of Diabetic Retinopathy in Type 2 Diabetes Patients in Correlation with the Duration of Diabetes[J].Exp Clin Endocrinol Diabetes,2018,126(9):570-576.[11]Salvotelli L,Stoico V,Perrone F,et al.Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program[J].J Diabetes Complications,2015,29(8):1066-1070.[12]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.[13]施洋,吴胜利,谢爱霞,等.新疆克拉玛依地区民汉2型糖尿病患病情况及影响因素分析[J].河北医药,2023,45(6):936-939.[14]Brath H,Kaser S,Tatschl C,et al.Rauchen, erhitzte Tabakprodukte, Alkohol und Diabetes mellitus (Update 2023)[Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023)][J].Wien Klin Wochenschr,2023,135(Suppl 1):84-90.[15]Stefan N,Roden M.Diabetes and Fatty Liver[J].Exp Clin Endocrinol Diabetes,2019,127(S01):S93-S96.[16]《缓解型糖尿病中国专家共识》编写专家委员会.缓解2型糖尿病中国专家共识[J].中国全科医学,2021,24(32):4037-4048.[17]Antonetti DA,Klein R,Gardner TW.Diabetic retinopathy[J].N Engl J Med,2012,366(13):1227-1239.[18]Vinik AI.Clinical Practice. Diabetic Sensory and Motor Neuropathy[J].N Engl J Med,2016,374(15):1455-1464.[19]Ang L,Jaiswal M,Martin C,et al.Glucose control and diabetic neuropathy: lessons from recent large clinical trials[J].Curr Diab Rep,2014,14(9):528.[20]中国微循环学会糖尿病与微循环专业委员会.糖尿病微循环障碍临床用药专家共识(2021年版)[J].中国医学前沿杂志(电子版),2021,13(4):49-57.[21]de Zeeuw D,Parving HH,Henning RH.Microalbuminuria as an early marker for cardiovascular disease[J].J Am Soc Nephrol,2006,17(8):2100-2105.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(02):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(02):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(02):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(02):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(02):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(02):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(02):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(02):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(02):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]

更新日期/Last Update: 1900-01-01